These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7140608)

  • 1. Practical therapeutics--drug therapy.
    Juma FD
    East Afr Med J; 1982 Apr; 59(4):238-40. PubMed ID: 7140608
    [No Abstract]   [Full Text] [Related]  

  • 2. Age: a growing P & T concern.
    Lipman AG
    Hosp Formul; 1983 May; 18(5):475. PubMed ID: 10260197
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical and non-pharmaceutical therapeutics. Regulation and recommendations].
    Bouvenot G; Villani P
    Rev Prat; 2004 Feb; 54(3):331-8, 330. PubMed ID: 15134245
    [No Abstract]   [Full Text] [Related]  

  • 4. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ideology of drug therapy].
    Mercolli C
    Krankenpfl Soins Infirm; 1982 Feb; (2):56. PubMed ID: 6278212
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy assessment: areas of focus.
    Qual Lett Healthc Lead; 1996 Dec; 8(10):16-7. PubMed ID: 10163849
    [No Abstract]   [Full Text] [Related]  

  • 8. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient compliance as a partial problem in drug therapy].
    Schrey A
    Med Welt; 1981 Feb; 32(7):214-8. PubMed ID: 7207157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Are children in the shadow region of drug therapy].
    Hämäläinen M
    Duodecim; 2001; 117(18):1781-2. PubMed ID: 12181973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contemporary drug therapy: dramatic dangers and the optimism of ability].
    Mukhin NA; Moiseev SV; Fomin VV
    Klin Med (Mosk); 2005; 83(8):13-9. PubMed ID: 16218358
    [No Abstract]   [Full Text] [Related]  

  • 12. Pitfalls in geriatric drug therapy.
    Gordon M
    Resid Staff Physician; 1983 Aug; 29(8):10PC-11PC, 14PC-15PC. PubMed ID: 10262519
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to enhancing the quality of drug therapy. A joint statement by the CMA and the Canadian Pharmaceutical Association. Canadian Medical Association.
    CMAJ; 1996 Sep; 155(6):784A-784F. PubMed ID: 8823225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug development--from receptor research to therapy].
    Lammintausta R; Scheinin M
    Duodecim; 1998; 114(10):957-66. PubMed ID: 11524784
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy in the aged: too much and too little, what to do? A new evaluation system: fit for the aged (FORTA)].
    Werner H
    Dtsch Med Wochenschr; 2009 Jan; 134(3):95-6; author reply 96. PubMed ID: 19142841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Examination of drug therapy quality in obligatory medical insurance system].
    Baturin VA; Bulgakova TIa; Isaeva TI; Kolodiĭchuk EV; Shchetinin EV
    Med Tr Prom Ekol; 1999; (12):37-9. PubMed ID: 11965739
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical considerations for pharmacogenetic testing.
    Wedlund PJ
    MLO Med Lab Obs; 2001 Sep; 33(9):16-21, 23; quiz 24-5. PubMed ID: 11569125
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacy's framework for drug therapy management.
    Penna P
    Manag Care Interface; 2002 Jul; 15(7):33-4. PubMed ID: 12143294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage].
    Gladtke E
    Med Welt; 1981 Feb; 32(7):219-24. PubMed ID: 7207158
    [No Abstract]   [Full Text] [Related]  

  • 20. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.